Metronidazole benzoate is a nitroimidazole-class antibiotic and antiprotozoal medication used to treat conditions such as bacterial vaginosis, pelvic inflammatory disease, and endocarditis by inhibiting… Read more






Metronidazole benzoate is a nitroimidazole-class antibiotic and antiprotozoal medication used to treat conditions such as bacterial vaginosis, pelvic inflammatory disease, and endocarditis by inhibiting nucleic acid synthesis and disrupting microbial DNA. This category provides essential pharmaceutical reference standards for the parent drug and its related substances, including specific pharmacopeial and non-pharmacopeial impurities, degradation products, and metabolites. Analytical laboratories rely on these high-quality materials for accurate impurity profiling, method validation, and routine quality control testing. The inclusion of stable isotope-labelled compounds allows for precise quantification in complex biological matrices, ensuring that analytical procedures meet regulatory requirements. By providing access to certified standards for associated compounds like benzoic acid derivatives and related nitroimidazole impurities, these products facilitate rigorous safety assessments and consistency in the pharmaceutical manufacturing and testing of this therapeutic agent.